{"nct_id":"NCT05613088","title":"A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2023-02-01","start_date_type":"ACTUAL","primary_completion_date":"2024-06-17","primary_completion_date_type":"ACTUAL","completion_date":"2026-10-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}